EMZIGO M 12.5/500MG TAB

EMZIGO M 12.5/500MG is a combination tablet containing Empagliflozin 12.5mg and Metformin HCl 500mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they provide effective glycemic management for patients requiring combination therapy. Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient. Always use as directed by your healthcare provider.